127 related articles for article (PubMed ID: 31209263)
1. A landmark in drug discovery based on complex natural product synthesis.
Kawano S; Ito K; Yahata K; Kira K; Abe T; Akagi T; Asano M; Iso K; Sato Y; Matsuura F; Ohashi I; Matsumoto Y; Isomura M; Sasaki T; Fukuyama T; Miyashita Y; Kaburagi Y; Yokoi A; Asano O; Owa T; Kishi Y
Sci Rep; 2019 Jun; 9(1):8656. PubMed ID: 31209263
[TBL] [Abstract][Full Text] [Related]
2. Selected hybrid natural products as tubulin modulators.
Dasari B; Jimmidi R; Arya P
Eur J Med Chem; 2015 Apr; 94():497-508. PubMed ID: 25455639
[TBL] [Abstract][Full Text] [Related]
3. Complex synthesis yields breast-cancer therapy.
Ledford H
Nature; 2010 Dec; 468(7324):608-9. PubMed ID: 21124423
[No Abstract] [Full Text] [Related]
4. In vitro and in vivo anticancer activities of synthetic macrocyclic ketone analogues of halichondrin B.
Towle MJ; Salvato KA; Budrow J; Wels BF; Kuznetsov G; Aalfs KK; Welsh S; Zheng W; Seletsky BM; Palme MH; Habgood GJ; Singer LA; Dipietro LV; Wang Y; Chen JJ; Quincy DA; Davis A; Yoshimatsu K; Kishi Y; Yu MJ; Littlefield BA
Cancer Res; 2001 Feb; 61(3):1013-21. PubMed ID: 11221827
[TBL] [Abstract][Full Text] [Related]
5. Highly convergent synthesis of peluroside A.
Floreancig PE
Angew Chem Int Ed Engl; 2009; 48(42):7736-9. PubMed ID: 19739167
[No Abstract] [Full Text] [Related]
6. Acetyl-CoA carboxylase rewires cancer metabolism to allow cancer cells to survive inhibition of the Warburg effect by cetuximab.
Luo J; Hong Y; Lu Y; Qiu S; Chaganty BK; Zhang L; Wang X; Li Q; Fan Z
Cancer Lett; 2017 Jan; 384():39-49. PubMed ID: 27693630
[TBL] [Abstract][Full Text] [Related]
7. Scaffold Diversity Inspired by the Natural Product Evodiamine: Discovery of Highly Potent and Multitargeting Antitumor Agents.
Wang S; Fang K; Dong G; Chen S; Liu N; Miao Z; Yao J; Li J; Zhang W; Sheng C
J Med Chem; 2015 Aug; 58(16):6678-96. PubMed ID: 26226379
[TBL] [Abstract][Full Text] [Related]
8. Intra-tumor AvidinOX allows efficacy of low dose systemic biotinylated Cetuximab in a model of head and neck cancer.
Vesci L; Milazzo FM; Anastasi AM; Petronzelli F; Chiapparino C; Carollo V; Roscilli G; Marra E; Luberto L; Aurisicchio L; Pacello ML; Spagnoli LG; De Santis R
Oncotarget; 2016 Jan; 7(1):914-28. PubMed ID: 26575422
[TBL] [Abstract][Full Text] [Related]
9. Honokiol inhibits in vitro and in vivo growth of oral squamous cell carcinoma through induction of apoptosis, cell cycle arrest and autophagy.
Huang KJ; Kuo CH; Chen SH; Lin CY; Lee YR
J Cell Mol Med; 2018 Mar; 22(3):1894-1908. PubMed ID: 29363886
[TBL] [Abstract][Full Text] [Related]
10. Basal subtype is predictive for response to cetuximab treatment in patient-derived xenografts of squamous cell head and neck cancer.
Klinghammer K; Otto R; Raguse JD; Albers AE; Tinhofer I; Fichtner I; Leser U; Keilholz U; Hoffmann J
Int J Cancer; 2017 Sep; 141(6):1215-1221. PubMed ID: 28560858
[TBL] [Abstract][Full Text] [Related]
11. Comparative antitumor activities of halichondrins and vinblastine against human tumor xenografts.
Fodstad O; Breistøl K; Pettit GR; Shoemaker RH; Boyd MR
J Exp Ther Oncol; 1996 Mar; 1(2):119-25. PubMed ID: 9414395
[TBL] [Abstract][Full Text] [Related]
12. Total synthesis of halichondrin A, the missing member in the halichondrin class of natural products.
Ueda A; Yamamoto A; Kato D; Kishi Y
J Am Chem Soc; 2014 Apr; 136(13):5171-6. PubMed ID: 24606005
[TBL] [Abstract][Full Text] [Related]
13. Design, synthesis and biological evaluation of paclitaxel-mimics possessing only the oxetane D-ring and side chain structures.
Chen XX; Gao F; Wang Q; Huang X; Wang D
Fitoterapia; 2014 Jan; 92():111-5. PubMed ID: 24211350
[TBL] [Abstract][Full Text] [Related]
14. HER3 Targeting Sensitizes HNSCC to Cetuximab by Reducing HER3 Activity and HER2/HER3 Dimerization: Evidence from Cell Line and Patient-Derived Xenograft Models.
Wang D; Qian G; Zhang H; Magliocca KR; Nannapaneni S; Amin AR; Rossi M; Patel M; El-Deiry M; Wadsworth JT; Chen Z; Khuri FR; Shin DM; Saba NF; Chen ZG
Clin Cancer Res; 2017 Feb; 23(3):677-686. PubMed ID: 27358485
[TBL] [Abstract][Full Text] [Related]
15. Ammonium tetrathiomolybdate enhances the antitumor effects of cetuximab via the suppression of osteoclastogenesis in head and neck squamous carcinoma.
Morisawa A; Okui T; Shimo T; Ibaragi S; Okusha Y; Ono M; Nguyen TTH; Hassan NMM; Sasaki A
Int J Oncol; 2018 Mar; 52(3):989-999. PubMed ID: 29328370
[TBL] [Abstract][Full Text] [Related]
16. Cetuximab and methotrexate in recurrent or metastatic head and neck squamous cell carcinoma-A single institution analysis of 54 patients.
Sukari A; Nagasaka M; Diab M; Al Sibai K; Atassi B; Elayoubi JA; Kim S; Küçük Ö
Clin Otolaryngol; 2019 Jul; 44(4):639-643. PubMed ID: 30784192
[No Abstract] [Full Text] [Related]
17. [Observation of the antitumor effect of endostar combined with docetaxel under different administration sequences].
Yuan J; Wu CW; Liu ZJ; Wei XY; Li K
Zhonghua Zhong Liu Za Zhi; 2010 Aug; 32(8):580-5. PubMed ID: 21122408
[TBL] [Abstract][Full Text] [Related]
18. Nimotuzumab increases the anti-tumor effect of photodynamic therapy in an oral tumor model.
Bhuvaneswari R; Ng QF; Thong PS; Soo KC
Oncotarget; 2015 May; 6(15):13487-505. PubMed ID: 25918252
[TBL] [Abstract][Full Text] [Related]
19. Cetuximab sensitivity of head and neck squamous cell carcinoma xenografts is associated with treatment-induced reduction in EGFR, pEGFR, and pSrc.
Jedlinski A; Garvin S; Johansson AC; Edqvist PH; Ponten F; Roberg K
J Oral Pathol Med; 2017 Oct; 46(9):717-724. PubMed ID: 28036101
[TBL] [Abstract][Full Text] [Related]
20. Leiodermatolide, a novel marine natural product, has potent cytotoxic and antimitotic activity against cancer cells, appears to affect microtubule dynamics, and exhibits antitumor activity.
Guzmán EA; Xu Q; Pitts TP; Mitsuhashi KO; Baker C; Linley PA; Oestreicher J; Tendyke K; Winder PL; Suh EM; Wright AE
Int J Cancer; 2016 Nov; 139(9):2116-26. PubMed ID: 27376928
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
